Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Dose Ifosfamide, Carboplatin and Etoposide With Amifostine Chemoprotection

NCT00003657 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT00003657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Dose Ifosfamide, Carboplatin and Etoposide With Amifostine Chemoprotection
Lead sponsor
Dana-Farber Cancer Institute
Phase
Phase 2
Overall status
Completed
Start date
July 31, 1998
Completion date
June 30, 2002
Enrollment
24 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, brain and central nervous system tumors, carcinoma of unknown primary, extragonadal germ cell tumor, head and neck cancer, kidney cancer, lung cancer, ovarian cancer, sarcoma, testicular germ cell tumor, unspecified adult solid tumor, protocol specific